Civil Aviation Industry Trends, Demand, Production, Analysis and Forecast to 2028: Grand View Research Inc.

 COVID-19 Impact On Civil Aviation Industry, Growth & Trends

The outbreak of the COVID-19 pandemic has taken a severe toll on the global civil aviation industry, which has had to confront considerable revenue losses over the past year. The industry is poised for a gradual recovery and is expected to reach USD 1.09 trillion by 2028, registering a CAGR of 8.9% from 2021 to 2028, according to a new report by Grand View Research, Inc. Airline operators took a drastic hit as several governments across the world imposed restrictions on the movement of people as part of the efforts to arrest the spread of coronavirus and people preferred keeping travel-related activities at bay owing to concerns over the risk of contraction of the disease. The demand for air travel continued to plummet as a result.

The initial response to the outbreak of the pandemic was limited to prohibiting travelers from China. However, with the rapid spread of coronavirus across the world, several governments went on to impose travel bans. The World Health Organization (WHO) coordinated with various governments to issue a global health advisory and urged people across the globe to avoid all travel activities. The subsequent dramatic decline in air passenger traffic following such containment measures poses a severe threat to numerous incumbents of the aviation industry.

At this juncture, airline operators are focusing aggressively on reviving themselves amid the challenging situation. Airlines are also focusing on regaining passengers' trust by ensuring sanitized cabins and guaranteeing touchless travel. At the same time, several governments worldwide are instilling cash in the aviation industry. Numerous airlines in the U.S. and the Gulf have already become solvent, even with reduced revenue inflows, leveraging the support they received from their respective governments.

Request a free sample copy or view report summary: COVID-19 Impact On Civil Aviation Industry Report

COVID-19 Impact On Civil Aviation Industry, Report Highlights

• Both domestic and international air passenger traffic plummeted approximately 60% over the year in 2020. However, domestic air travel is recovering ahead of international air travel as various governments are easing the restrictions on the movement of people and permitting domestic air travel
• Airlines are putting a strong emphasis on enhancing the traveling experience by implementing solutions based on the latest technologies, such as thermal scanning, biometric scanning, and UV ray disinfection
• Asia Pacific is expected to recover faster than other regional markets. The level of consumer confidence among passengers in the region has been improving as a result of the efforts being pursued by the governments in the region to contain the spread of coronavirus
• Operators, including American Airlines, Alaska Airlines, and South West Airlines, are adopting unique marketing plans to attract passengers as part of the efforts to augment the revenues

Access Press Release@ https://www.grandviewresearch.com/press-release/global-civil-aviation-industry

Civil Aviation Industry Segmentation

Grand View Research has segmented the global COVID-19 impact on civil aviation industry based on region:

COVID-19 Impact on Civil Aviation Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microneedling Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Microneedling Market Growth & Trends

The global microneedling market size is expected to reach USD 992.49 million by 2028, registering a CAGR of 7.9% over the forecast period, according to a new report by Grand View Research, Inc. It is a minimally invasive aesthetic procedure that involves superficial and controlled puncturing (micro-puncturing) to the skin by using a rolling device embedded with small fine needles made of either metal or silicon and is performed under local anesthesia. According to NCBI, it was initially introduced for skin rejuvenation; however, recently it has been used for treating skin conditions like acne scar, post-traumatic burn, alopecia, stretch marks, hyperpigmentation, etc. due to the proven effectiveness of the treatment.

As stated by Healthline, microneedling, also known as collagen induction therapy, boosts the production of collagen in the epidermis by breaking down hardened scar strands and allows the epidermis to revascularize. The introduction of at-home devices like dermarollers (0.2 to 0.3mm) has further boosted the market growth. Moreover, factors like rising aesthetic consciousness among the population, high procedure effectiveness, lower costs as compared to other aesthetic procedures, and availability of at-home products are expected to propel market growth.

The COVID-19 pandemic has adversely affected the overall aesthetic industry along with this market, especially in the first and second quarters of 2020, due to restrictions on the elective aesthetic procedure. However, many dermatologists believe that COVID-19 may act as a springboard that will drastically increase patient footfall for aesthetic treatments post-pandemic. For instance, post-lockdown, the number of first-time attendees to dermatology clinics increased by 78% in the U.K. Moreover, the online sales of beauty tools and products including dermarollers increased during the pandemic.

Request a free sample copy or view report summary: Microneedling Market Report

Microneedling Market Report Highlights

• The RF microneedling product segment accounted for the highest revenue share in 2020 due to high demand for these products as they provide more prominent results and safety than manual procedures
• Dermapen segment accounted for the largest share of over 38% in 2020 and is expected to retain the leading position over the forecast period
• The skin rejuvenation application segment held the highest revenue share in 2020. Skin rejuvenation procedures are among the most frequently carried out minimally aesthetic procedures globally
• North America held the highest market share in 2020. However, Asia Pacific is expected to register the fastest CAGR over the forecast period due to the availability of skilled professionals, advanced techniques, and cheaper treatment costs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microneedling-market

Microneedling Market Segmentation

Grand View Research has segmented the global microneedling market on the basis of type, product, needle material, application, and region:

Microneedling Type Outlook (Revenue, USD Million, 2016 - 2028)

• Laser
• RF

Microneedling Product Outlook (Revenue, USD Million, 2016 - 2028)

• Derma-stamp
• Dermapen
• Dermarollers

Microneedling Needle Material Outlook (Revenue, USD Million, 2016 - 2028)

• Silicon
• Metal
• Glass Hollow

Microneedling Application Outlook (Revenue, USD Million, 2016 - 2028)

• Skin Rejuvenation
• Acne Scar
• Traumatic & Surgical Scars
• Others

Microneedling Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Microneedling Market

• Lumenis
• Cutera
• Cynosure
• Endymed Medical
• Candela Medical
• Dermaconcepts
• Eclipse Aesthetics
• Dermaquip
• Lutronic
• Dermaroller GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Branched Stent Grafts Market Size Is Anticipated To Reach USD 477.53 Million by 2028

 Branched Stent Grafts Market Growth & Trends

The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc. Continued robust growth in segments is an outcome of the growing diagnostic capturing of pre-ruptured aneurysms, expanding clinical coverage, and an overarching trend for endovascular aneurysm repair. In addition, the preference for endovascular treatment for aortic aneurysms further boosts the market growth.

Around 28 million vascular surgeries have been postponed or canceled globally at the peak of the COVID-19 pandemic, which can seriously affect the market. Restrictions on the movement of goods and people gradually led to a decline in the uptake of nonelective surgeries, such as those resulting from trauma or acute conditions. In addition, extended factory closures by companies in several countries slowed down the manufacturing of products.

With the rapid increase in the elderly population worldwide, the frequency of aortic aneurysms is likely to increase, which, in turn, is expected to contribute to market growth during the forecast period. In the U.S., aortic aneurysms were the leading cause of 9,923 deaths in 2018. Thoracic aortic aneurysm and AAA are types of aortic aneurysms; aneurysms can also occur in other parts of the body.

The global market is fairly competitive. The most notable participants in the market are Medtronic, Terumo Corp., and Cardinal Health (Cordis). Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in March 2021, Medtronic collaborated with Spectrum Health to drive value in healthcare and improve outcomes for patients in West Michigan. In September 2020, Terumo Aortic launched the TREO Abdominal Aortic Stent-Graft System to expand the company’s aortic solutions offerings.

Request a free sample copy or view report summary: Branched Stent Grafts Market Report

Branched Stent Grafts Market Report Highlights

• Iliac stents are expected to grow at a CAGR of 5.9% during the forecast period owing to the high technological advancements in this segment
• The chimney segment is anticipated to grow at the fastest CAGR of more than 8% during the forecast period owing to the growing application scope of these products
• In 2021, North America held the dominant share of the global market owing to the increased burden of vascular diseases
• Asia Pacific is expected to be the fastest-growing regional market from 2021 to 2028 due to the growing presence of key companies, such as Microport Scientific Corp. and Medtronic, Inc., in the region
• Europe is expected to hold the second-largest market share by 2028 due to high disposable income levels, the presence of developed economies, and the availability of well-established healthcare infrastructure & skilled professionals

Access Press Release@ https://www.grandviewresearch.com/press-release/global-branched-stent-grafts-market

Branched Stent Grafts Market Segmentation

Grand View Research has segmented the global branched stent grafts market on the basis of type, application, and region:

Branched Stent Grafts Type Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• Iliac Stent
• Others

Branched Stent Grafts Application Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• EVAR
  • FEVAR
  • Chimney
  • Others

Branched Stent Grafts Regional Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Greece
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Branched Stent Grafts Market

• Medtronic
• Biotronik
• Alvimedica
• Endocor GmbH
• Eucatech AG
• Merit Medical Systems
• Abbott
• Cook Medical
• Cardinal Health (Cordis)
• Boston Scientific Corp.
• Terumo Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopsy Guidance System Market Estimated to Experience a Hike in Growth by 2028: Grand View Research Inc.

 Biopsy Guidance System Market Growth & Trends

The global biopsy guidance system market size is expected to reach USD 1,383.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2021 to 2028. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Request a free sample copy or view report summary: Biopsy Guidance System Market Report

Biopsy Guidance System Market Report Highlights

• In terms of product, the stereotactic guided biopsy segment held the largest revenue share in 2020 and the ultrasound-guided biopsy segment is estimated to be the fastest-growing segment over the forecast period
• In terms of application, the brain biopsy segment held the largest revenue share in 2020 and the breast biopsy segment is estimated to be the fastest-growing segment during the forecast period. The rising prevalence of brain cancer is the major factor driving the demand for brain biopsies
• In terms of end-use, the hospital segment held the largest revenue share in 2020. The hospital segment's dominance is majorly attributed to the higher biopsy guiding system utilization in hospitals
• North America dominated the market in 2020 owing to numerous factors such as enhanced infrastructure, rising patient awareness, and the presence of key players in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopsy-guidance-systems-market

Biopsy Guidance System Market Segmentation

Grand View Research has segmented the global biopsy guidance system market on the basis of product, application, end-use, and region:

Biopsy Guidance System Product Outlook (Revenue, USD Million, 2016 - 2028)

• Stereotactic Guided Biopsy
• Ultrasound Guided Biopsy
• MRI Guided Biopsy

Biopsy Guidance System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Brain Biopsy
• Breast Biopsy
• Other Applications

Biopsy Guidance System End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Research and Academic Institutes

Biopsy Guidance System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Biopsy Guidance System Market

• Becton, Dickinson, and Company
• Hologic, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• ARGON MEDICAL
• Boston Scientific Corporation
• INRAD Inc.
• Cook Medical
• PLANMED OY

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Cancer Biopsy Market Predicted to Witness Steady Growth During the Forecast Period

 U.S. Cancer Biopsy Market Growth & Trends

The U.S. cancer biopsy market size is expected to reach USD 15.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.0% from 2021 to 2028. The increasing usage of technologically advanced devices for the early detection of diseases is one of the key factors driving the market.

A significant transaction from tumor to liquid biopsy is anticipated to increase the adoption of this technique in the market. Acknowledging this trend, several operating entities have undertaken various initiatives to expand their biopsy kits portfolio. For instance, in June 2021, Biocept, Inc. and Quest Diagnostics collaborated to offer NGS-based liquid biopsy testing for lung cancer diagnosis.

Furthermore, supportive regulatory and reimbursement scenarios in the country have supplemented the market growth. The U.S. FDA is actively engaged in supporting the commercialization of cancer biopsy products and increasing the use of these assays in clinics. For instance, in March 2021, the U.S. FDA granted a breakthrough device designation to RaDaR-a liquid biopsy assay to detect minimal residual disease in early-stage cancer.

Request a free sample copy or view report summary: U.S. Cancer Biopsy Market Report

U.S. Cancer Biopsy Market Report Highlights

• The fine-needle aspiration type segment accounted for the largest revenue share in 2020 owing to it being a well-established approach for the initial diagnosis of most of the body lesions. Among various biopsy techniques, fine-needle aspiration has witnessed significant popularity in diagnostics
• By type, the others segment is expected to expand at the fastest CAGR of 15.2% from 2021 to 2028. Liquid biopsies are anticipated to witness considerable growth over the forecast period due to the advancements and increasing regulatory approvals in the U.S.
• Screening and monitoring emerged as a dominant application segment in 2020. Follow-up or repeat biopsy procedures are fueling the growth of this segment
• Key players are collaborating with biopharma developers to support their product development process

Access Press Release@ https://www.grandviewresearch.com/press-release/us-cancer-biopsy-market-analysis

U.S. Cancer Biopsy Market Segmentation

Grand View Research has segmented the U.S. cancer biopsy market on the basis of type, application, and site (organ):

U.S. Cancer Biopsy Type Outlook (Revenue, USD Million, 2017 - 2028)

• Fine-needle Aspiration
  • Pharma-use
  • Clinical-use
• Core Biopsy
  • Pharma-use
  • Clinical-use
• Surgical Biopsy
  • Pharma-use
  • Clinical-use
• Skin Biopsy /Punch Biopsy
  • Pharma-use
  • Clinical-use
• Others
  • Pharma-use
  • Clinical-use

U.S. Cancer Biopsy Application Outlook (Revenue, USD Million, 2017 - 2028)

• Screening & Monitoring
• Diagnostics
• Investigational & Translational Research
• Pharma & Biopharma Discovery & Development

U.S. Cancer Biopsy Site (Organ) Outlook (Revenue, USD Million, 2017 - 2028)

• Liver
• Breast
• Thyroid
• Prostate Gland
• Uterus & Cervix
• Kidney
• Bladder
• Lungs
• Pancreas
• Others

List of Key Players of U.S. Cancer Biopsy Market

• Becton, Dickinson and Company
• IZI Medical Products
• Johnson & Johnson
• Argon Medical
• Cook Medical
• Spectra Medical Devices, Inc.
• Medtronic plc.
• Boston Scientific Corporation
• Conmed Corporation
• INRAD, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Joint Replacement Market During 2021 – 2028 to Gain Robust Traction: Grand View Research Inc.

 Joint Replacement Market Growth & Trends

The global joint replacement market size is expected to reach USD 25.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.4% from 2021 to 2028. The growing incidence of orthopedic diseases and the increasing number of the target population are boosting the market growth.

According to the Centers for Disease Control and Prevention, 1 in every 4 adults in the U.S. is suffering from arthritis in 2019. In addition, it is projected that by 2040, approximately 78 million of the U.S. adult citizens aged 18 years or older will suffer from arthritis diagnosed by doctors. This upsurge in the number of patients suffering from arthritis is increasing the number of joint replacement surgeries.

Moreover, the increasing demand for minimally invasive joint replacement operations is likely to propel the market over the forecast period. In addition, growing awareness about day surgeries, increasing healthcare reimbursement, and rapid adoption of advanced technologies are some of the key factors expected to contribute to market growth over the coming years. The COVID 19 had negatively impacted the market in 2020. However, it started recovering during the third quarter of 2020 and is expected to pace up in the coming years.

Request a free sample copy or view report summary: Joint Replacement Market Report

Joint Replacement Market Report Highlights

• The knee replacement was the largest revenue-generating segment of the market in 2020. This contribution is mainly because of the increased demand for these surgeries and continuous technological advancements
• The cemented fixation segment dominated the market and accounted for the largest revenue share of over 49.0% in 2020. The associated advantages such as its low revision rate, better acceptance, lesser hospital stay among others are boosting segment growth
• The total replacement segment held the largest revenue share of over 64.0% in 2020. The growth can be attributed to the increased number of this kind of surgery and continuous technological advancements by the leading industry players
• The hospitals held the largest revenue share in 2020. The growth can be attributed to advanced treatment options and a large number of patient footfalls
• North America dominated the market in the year 2020. The growing target population and favorable reimbursement policies along with the advanced healthcare infrastructure are anticipated to contribute to market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-joint-replacement-market

Joint Replacement Market Segmentation

Grand View Research has segmented the global joint replacement market on the basis of product, fixation type, end-use, procedure, and region:

Joint Replacement Product Outlook (Revenue, USD Million, 2016 - 2028)

• Knees
• Hips
• Extremities
  • Upper
  • Lower

Joint Replacement Fixation Type Outlook (Revenue, USD Million, 2016 - 2028)

• Cemented
• Cementless
• Hybrid
• Reverse Hybrid

Joint Replacement End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Orthopedic Clinics
• Others

Joint Replacement Procedure Outlook (Revenue, USD Million, 2016 - 2028)

• Total Replacement
• Partial Replacement
• Others

Joint Replacement Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Joint Replacement Market

• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Stryker
• Zimmer Biomet
• Smith+Nephew
• DJO, LLC
• Arthrex, Inc.
• Exactech, Inc.
• Conformis
• MicroPort Orthopedics
• Corin Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Zero Trust Security Market Poised to Expand at a Robust Pace of USD 59.43 Billion Over 2028: Grand View Research Inc.

 Zero Trust Security Market Growth & Trends

The global zero trust security market size is expected to reach USD 59.43 billion by 2028, registering a CAGR of 15.2% from 2021 to 2028, according to a new study conducted by Grand View Research, Inc. The market is driven by the need to protect enterprise digital environments by averting lateral movement, leveraging network segmentation, simplifying granular user-access control, and implementing layer 7 threat prevention. The robust solutions for implementing a zero-trust security environment ensure the protection of computers, programs, and networks from unauthorized access. Moreover, preventing unwarranted access to critical data, as the adoption of technologies, such as cloud computing, Wi-Fi, and Internet of Things (IoT), coupled with outsourcing service, is increasing, is driving the growth of the market. The COVID-19 pandemic has further acted as a catalyst for market growth with enterprises investing in securing their networks, endpoints, and IT infrastructure with a zero-trust security framework.

The threat to digitally stored information from unauthorized access is also driven by changing technological landscape. While technology revolutionizes a business process, it also creates vulnerabilities in online protected data. In addition, while internet connectivity improves the operational task of the business by speeding up the process and improving accessibility, the risk of cyber attacks also increases rapidly. Moreover, the rapid expansion of operational data exposed to cyber adversaries through mobile, other edge devices, and IOT and the dependence of companies on third-party vendors and service providers are some of the prevailing supply chain trends increasing the risk of cyberattacks to access information. Therefore, the implementation of a security solution ensures a zero-trust security environment in the organization to mitigate the risks arising from various business activities and internet connectivity.

The application of the zero trust model is parallel to the concept of cybersecurity as it focuses on preventing intrusion by securing the digital network. Several countries across the world introduced laws to prevent cybercrime and data theft, which is vital for safeguarding the BFSI, IT, telecom, defense, and healthcare, other major sectors. The increasing internal and external threat of unauthorized data accessibility and cybercrime due to the political and personal interest of hackers or intruders for earning easy money further pressurizes governments to update their policies regularly. For instance, China updated its cyber policy on December 1, 2019, which instructs both Chinese and foreign public as well as private companies and organizations to secure their networks. The cyber law in the U.S. varies based on the business sector and includes Health Insurance Portability and Accountability Act, 2002 (HIPAA); Homeland Security Act that also includes Federal Information Security Management Act (FISMA), and 1996 Gramm-Leach-Billey Act. Such cyber laws further necessitate the need to secure networking structure and boost the demand for authentication and cyber-solution that ensures a zero-trust security environment.

Request a free sample copy or view report summary: Zero Trust Security Market Report

Zero Trust Security Market Report Highlights

• The Small and Medium Enterprises (SMEs) segment is anticipated to witness the fastest CAGR over the forecast period owing to increasing awareness and threat of unauthorized access during cyber attacks
• The multi-factor authentication segment led the global market in 2020 and will expand further at the fastest CAGR from 2021 to 2028
• The growth can be attributed to the need to overcome the challenges of revenue loss and data loss risks in the era of confidential and vulnerable data, as multi-factor authentication presents multiple layers of identity verification to grant access to an authorized individual
• North America led the global market in 2020 and will remain dominant even during the forecast years
• The growth is credited to the high-security investment from the large enterprises across the regional industries, such as BFSI, that are at constant risk of cyber attacks as well as internal fraudsters

Access Press Release@ https://www.grandviewresearch.com/press-release/global-zero-trust-security-market

Zero Trust Security Market Segmentation

Grand View Research has segmented the global zero trust security market on the basis of security type, deployment, organization size, authentication, application area, and region:

Zero Trust Security Type Outlook (Revenue, USD Million, 2017 - 2028)

• Network
• Data
• Endpoint
• Cloud
• Others

Zero Trust Security Deployment Outlook (Revenue, USD Million, 2017 - 2028)

• On-premises
• Cloud

Zero Trust Security Organization Size Outlook (Revenue, USD Million, 2017 - 2028)

• SMEs
• Large Enterprise

Zero Trust Security Authentication Outlook (Revenue, USD Million, 2017 – 2028)

• Single-factor Authentication
• Multi-factor Authentication

Zero Trust Security Application Area Outlook (Revenue, USD Million, 2017 - 2028)

• IT & Telecom
• BFSI
• Healthcare
• Retail
• Others

Zero Trust Security Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA

List of Key Players of Zero Trust Security Market

• Cisco Systems, Inc.
• Akamai Technologies
• Palo Alto Networks
• Check Point Software Technologies
• Trend Micro, Inc.
• IBM Corp.
• Symantec Corp.
• FireEye, Inc.
• McAfee Corp.
• Forcepoint
• Microsoft Corp.
• VMWare, Inc.
• Fortinet
• Cloudflare, Inc.
• SonicWall

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Deck Design Software Market Trends, Growth Prospects To 2028: Grand View Research Inc.

 North America Deck Design Software Market Growth & Trends

The North America deck design software market size is expected to reach USD 235.3 million by 2028, according to the new study conducted by Grand View Research, Inc. It is expected to expand at a CAGR of 13.0% from 2021 to 2028. Deck design software provides a certain degree of automation to architects/designers, allowing them to create detailed floor plans more easily. In comparison to hand-drafting a building design, deck design saves time and cost, subsequently creating market demand.

Investments in the real-estate sector have created ample opportunities for the implementation of deck design software. Furthermore, the pre-built templates and visualizations offered by the software favor its demand among real-estate developers. For instance, Fiberon’s Discovery Deck Designer features installation checklists and information about local Fiberon retailers and contractors to help users customize their deck designs easily.

Over the last few years, landscaping has gained prominence among Americans, paving the way for the larger implementation of these solutions. The COVID-19 pandemic has been fairly instrumental in piquing consumer interest in remodeling outdoor spaces with WFH being the new norm. Trends such as these are expected to create healthy opportunities for developers in the deck design industry.

Request a free sample copy or view report summary: North America Deck Design Software Market Report

North America Deck Design Software Market Report Highlights

• By deployment, the cloud segment is anticipated to register the highest CAGR of 13.8% over the forecast period. The popularity of the cloud segment is on the rise due to the plethora of benefits the technology offers in terms of cost and flexibility. Moreover, advancements in the field of cloud security are encouraging users to shift from the on-premise to cloud-based deployment model
• In terms of end use, the remodelers segment is expected to witness the fastest growth over the forecast period. A rise in the number of renovation projects is one of the primary factors contributing to the segment growth
• Based on application, the residential sector held the largest share of over 55.0% in 2020. The sudden shift to a WFH model during the COVID-19 pandemic has further driven investments in outdoor space remodeling in the region, subsequently favoring the demand for deck design software
• In North America, the U.S. held the largest share of over 85.0% in 2020. The dominant position of the U.S. in the North American market can be ascribed to the increased spending on real-estate construction, combined with the growing popularity of decks across households

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-deck-design-software-market-analysis

North America Deck Design Software Market Segmentation

Grand View Research has segmented the North America deck design software market on the basis of deployment, end use, application, and country:

North America Deck Design Software Deployment Outlook (Revenue, USD Million, 2017 - 2028)

• On-premise
• Cloud

North America Deck Design Software End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Architect & Builders
• Remodelers
• Interior Designers
• Others

North America Deck Design Software Application Outlook (Revenue, USD Million, 2017 - 2028)

• Residential
• Commercial

North America Deck Design Software Country Outlook (Revenue, USD Million, 2017 - 2028)

• US.
• Canada

List of Key Players of North America Deck Design Software Market

• AZEK Building Products (TimberTech)
• Chief Architect, Inc.
• Delta Software International LLC (CAD Pro)
• Fiberon
• Lowe’s
• Luxwood Software Tools
• MiTek Inc.
• Simpson Strong-Tie Company, Inc.
• SmartDraw, LLC
• Trex Company, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Centrifugal Blood Pumps Market Revenue is Expected to Reach USD 126.7 Million by 2028: Grand View Research Inc.

 Centrifugal Blood Pumps Market Growth & Trends

The global centrifugal blood pumps market size is estimated to reach USD 126.7 million by 2028, registering a CAGR of 5.4% over the forecast period, according to a new report by Grand View Research, Inc. Demand for centrifugal blood pumps is increasing owing to its several advantages such as low maintenance costs, small in size, and less capital investment. Thus, such advantages offered by centrifugal blood pumps are estimated to fuel the market growth during the forecast period.

Growing clinical experience and cardiotomy suction devices have led to a significant increase in usage of mechanical centrifugal blood pumps and to the improvement of outcomes after short and long-term support. As the interventional methods in the cardiovascular field continue to develop and a majority of critically ill patients undergo treatment, the demand for mechanical centrifugal blood pumps is increasing drastically in this field.

Changing lifestyles and an increase in the prevalence of lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as diabetes, obesity, and cardiovascular diseases coupled with the rising number of geriatric population are fueling the demand for cardiovascular procedures. Treatment of such diseases involves the use of cardiotomy suction devices, which, in turn, is expected to drive the market over the forecast period.

Request a free sample copy or view report summary: Centrifugal Blood Pumps Market Report

Centrifugal Blood Pumps Market Report Highlights

• The electronic segment held the largest revenue share in 2020. High product efficacy is a major factor augmenting segment growth
• The hospitals segment is predicted to grow at the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in hospitals as compared to other healthcare facilities
• North America held the largest revenue share in the market in 2020 and is predicted to maintain its dominance over the forecast period. This is attributable to strong per capita healthcare spending and favorable healthcare policies that have led to the introduction of cardiotomy suction devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-centrifugal-blood-pumps-market

Centrifugal Blood Pumps Market Segmentation

Grand View Research has segmented the global centrifugal blood pumps market on the basis of type, end use, and region:

Centrifugal Blood Pumps Type Outlook (Revenue, USD Million, 2016 - 2028)

• Electronic
• Mechanical

Centrifugal Blood Pumps End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Centrifugal Blood Pumps Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Centrifugal Blood Pumps Market

• Medtronic
• LivaNovaplc
• Qura srl
• Abbott Laboratories
• Terumo Corporation
• Braille Biomedica Ltd.
• Getinge AB
• 3M
• Baxter International

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

MiRNA Sequencing And Assay Market Is Projected To Reach Approximately USD 597.8 Million By 2028: Grand View Research Inc.

 miRNA Sequencing And Assay Market Growth & Trends 

The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.0% from 2021 to 2028. Prominent players, such as Illumina, PerkinElmer, Qiagen, and others offer advanced miRNA sequencing products for multiple clinical applications. Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.

The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry. For instance, several research studies demonstrate that miRNAs can be used as efficient biomarkers in the diagnosis and prognosis of cancer (breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and nervous system disorders. Therefore, miRNA sequence analysis is increasingly employed to analyze gene regulation in clinical disorders.

As plasma from COVID-19 recovered patients is rich in antiviral miRNAs and antibodies, it has been employed to treat SARS-CoV-2 infected patients. This has led to an increase in research studies that focus on the sequence analysis of miRNAs (microRNA) from the patient as well as the virus.

Request a free sample copy or view report summary: miRNA Sequencing And Assay Market Report

miRNA Sequencing And Assay Market Report Highlights

• The product segment dominated the market and accounted for the largest revenue share in 2020. The commercial presence of multiple players that offer extensive kits, consumables, and instruments for specialized applications contribute to segment growth
• Small and mid-sized research entities face financial limitations to install sequencing equipment owing to their high cost. Therefore, these organizations approach service providers. This is expected to drive the services segment with the fastest CAGR over the forecast period
• Sequencing by synthesis holds a major share of the technology segment owing to its high sensitivity, fast turnaround time, and high throughput
• Additionally, this technology is playing important role in the detection of mutations in tumor tissue which helps to develop targeted and personalized therapies
• The sequencing workflow segment held the largest revenue share in 2020 and is expected to witness the fastest CAGR during the forecast period as it is the most important and crucial step of the workflow
• The cancer application segment generated the largest revenue share in 2020 owing to ongoing extensive research in cancer using miRNA as a biomarker to study diagnosis and prognosis of cancer and to develop novel therapies
• Furthermore, an increase in the number of cancer patients globally drives segment growth
• Research and academic institutions are one of the major revenue generators of the market as miRNA sequencing and assay techniques and associated products are being widely used in various research studies conducted by research and academic institutes
• In Asia Pacific, the market is anticipated to register a lucrative growth rate throughout the forecast owing to the presence of a huge target population, growing establishment of healthcare, and high unmet clinical needs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mirna-sequencing-assay-market

miRNA Sequencing And Assay Market Segmentation

Grand View Research has segmented the global miRNA sequencing and assay market on the basis of product & service, technology, workflow, application, end-use, and region:

miRNA Sequencing And Assay Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

• Products
  • Library Preparation Kits
  • Sequencing Consumables
  • Instruments
• Services

miRNA Sequencing And Assay Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Sequencing (Seq.) By Synthesis
• By Oligonucleotide Ligation and Detection (SOLiD)
• Nanopore Seq.
• Sanger Seq.
• Single Molecule Real-time (SMRT) Seq.

miRNA Sequencing And Assay Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Library Preparation
• Sequencing
• Data Analysis & Storage

miRNA Sequencing And Assay Application Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Polyglutamine Diseases
• Autoimmune Disease
• Schizophrenia
• Others

miRNA Sequencing And Assay End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical & Biotechnology Industry
• Research and Academic Institutes
• Contract Research Organizations

miRNA Sequencing And Assay Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Market Players of miRNA Sequencing And Assay Market

• Thermo Fisher Scientific, Inc
• Illumina, Inc.
• QIAGEN
• PerkinElmer, Inc.
• Abcam plc
• New England Biolabs
• Takara Bio Inc.
• Lexogen GmbH
• Norgen Biotek Corp
• Maravai LifeSciences
• HTG Molecular Diagnostics, Inc.
• Meridian Bioscience, Inc.
• System Biosciences, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.